BSE Live
Apr 07, 16:01Prev. Close
59.72
Open Price
59.72
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Aspira Pathlab & Diagnostics (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.10 | 0.39 | 0.48 | 0.12 | 1.30 | |
| Diluted EPS (Rs.) | 0.39 | 0.39 | 0.48 | 0.12 | 1.30 | |
| Cash EPS (Rs.) | 0.10 | 0.39 | 0.49 | 0.12 | 1.30 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 16.05 | 15.68 | 15.28 | 14.80 | 14.67 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 16.05 | 15.68 | 15.28 | 14.80 | 14.67 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | 0.29 | 0.57 | 0.75 | 0.21 | 1.89 | |
| PBIT/Share (Rs.) | 0.29 | 0.57 | 0.75 | 0.21 | 1.89 | |
| PBT/Share (Rs.) | 0.29 | 0.57 | 0.75 | 0.18 | 1.89 | |
| Net Profit/Share (Rs.) | 0.10 | 0.39 | 0.49 | 0.12 | 1.30 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Networth / Equity (%) | 0.64 | 2.51 | 3.17 | 0.82 | 8.88 | |
| Return on Capital Employed (%) | 0.64 | 2.51 | 3.17 | 0.82 | 8.88 | |
| Return on Assets (%) | 0.61 | 2.51 | 3.17 | 0.82 | 7.77 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 18.56 | 627.84 | 1,358.88 | 1,315.78 | 7.91 | |
| Quick Ratio (X) | 18.56 | 627.84 | 1,358.88 | 626.89 | 7.91 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
25.02.2026
Aspira Pathlab Standalone December 2025 Net Sales at Rs 5.12 crore, down 5.34% Y-o-Y
13.08.2025
Aspira Pathlab Consolidated June 2025 Net Sales at Rs 5.25 crore, up 13.17% Y-o-Y
19.05.2025
Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y
10.02.2025
Aspira Pathlab Standalone December 2024 Net Sales at Rs 5.41 crore, up 56.21% Y-o-Y